Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,616Revenue (TTM) $M7,503Net Margin (%)9.0Altman Z-Score3.5
Enterprise Value $M15,893EPS (TTM) $4.7Operating Margin %16.5Piotroski F-Score6
P/E(ttm)19.1Beneish M-Score-2.6Pre-tax Margin (%)14.0Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %5.9Quick Ratio1.5Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %4.2Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow16.7y-y EBITDA Growth Rate %-8.4ROA % (ttm)6.7Higher Current Ratio y-yY
Dividend Yield %1.8PEG4.7ROE % (ttm)14.6Less Shares Outstanding y-yY
Payout Ratio %34.0Shares Outstanding M139ROIC % (ttm)9.9Gross Margin Increase y-yY

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXChris Davis 2016-09-30 Reduce-1.09%$80.92 - $86.36
($83.98)
$ 91.008%Reduce -92.68%239,896
DGXJoel Greenblatt 2016-09-30 Add0.14%$80.92 - $86.36
($83.98)
$ 91.008%Add 73.71%308,220
DGXJohn Rogers 2016-09-30 Reduce-0.05%$80.92 - $86.36
($83.98)
$ 91.008%Reduce -10.90%404,984
DGXDavid Dreman 2016-09-30 Reduce-0.04%$80.92 - $86.36
($83.98)
$ 91.008%Reduce -5.73%12,702
DGXCharles Brandes 2016-09-30 Reduce-0.01%$80.92 - $86.36
($83.98)
$ 91.008%Reduce -3.58%141,534
DGXJohn Rogers 2016-06-30 Reduce-0.25%$71.43 - $81.41
($76.08)
$ 91.0020%Reduce -39.16%454,535
DGXJoel Greenblatt 2016-06-30 Reduce-0.06%$71.43 - $81.41
($76.08)
$ 91.0020%Reduce -28.80%177,438
DGXCharles Brandes 2016-06-30 Reduce-0.02%$71.43 - $81.41
($76.08)
$ 91.0020%Reduce -9.77%146,794
DGXChris Davis 2016-06-30 Reduce-0.01%$71.43 - $81.41
($76.08)
$ 91.0020%Reduce -1.06%3,279,494
DGXDavid Dreman 2016-06-30 Reduce$71.43 - $81.41
($76.08)
$ 91.0020%Reduce -4.16%13,474
DGXDavid Dreman 2016-03-31 Reduce-0.12%$60.54 - $72.26
($67.03)
$ 91.0036%Reduce -28.32%14,059
DGXChris Davis 2016-03-31 Reduce-0.08%$60.54 - $72.26
($67.03)
$ 91.0036%Reduce -7.69%3,314,772
DGXJohn Rogers 2016-03-31 Add0.05%$60.54 - $72.26
($67.03)
$ 91.0036%Add 7.77%747,094
DGXJoel Greenblatt 2016-03-31 Reduce-0.02%$60.54 - $72.26
($67.03)
$ 91.0036%Reduce -7.79%249,221
DGXCharles Brandes 2016-03-31 Reduce-0.01%$60.54 - $72.26
($67.03)
$ 91.0036%Reduce -3.73%162,685
DGXJoel Greenblatt 2015-12-31 Reduce-0.2%$61.58 - $72.11
($67.4)
$ 91.0035%Reduce -54.96%270,275
DGXChris Davis 2015-12-31 Reduce-0.16%$61.58 - $72.11
($67.4)
$ 91.0035%Reduce -14.58%3,590,857
DGXJohn Rogers 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 91.0035%Reduce -0.36%693,253
DGXDavid Dreman 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 91.0035%Reduce -1.51%19,614
DGXCharles Brandes 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 91.0035%Reduce -0.84%168,985
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PFEIFFER GARY MDirector 2016-11-15Sell42,643$85.097.17view
BRITELL JENNE KDirector 2016-08-19Sell4,000$84.767.59view
BRITELL JENNE KDirector 2016-08-10Sell4,000$85.27.03view
LEIDEN JEFFREY MDirector 2016-08-03Sell6,345$85.626.51view
ZIEGLER JOHN BDirector 2016-07-25Sell1,000$84.368.1view
Doherty Catherine T.SVP, Clin. Franchise Solutions 2016-05-27Sell47,334$77.2718.01view
BRITELL JENNE KDirector 2016-05-12Sell8,000$75.6820.49view
Cunningham EverettSVP, Commercial 2016-05-09Sell56,312$76.2619.58view
Cunningham EverettSVP, Commercial 2016-05-06Sell50,447$7619.99view
Doherty Catherine T.SVP, Clin. Franchise Solutions 2016-04-25Sell29,550$74.4522.48view

Press Releases about DGX :

Quarterly/Annual Reports about DGX:

News about DGX:

Articles On GuruFocus.com
7 Profitable Companies With Strong Yields Jan 10 2017 
A Solid 13% Dividend Increase, Compelling Valuation Nov 28 2016 
6 Stocks to Watch Oct 04 2016 
7 Best Stocks For Value Investors This Week - 7/30/16 Aug 01 2016 
Companies Hit 52-Week Highs Jul 19 2016 
Royce Special Equity Multi-Cap Fund Mar 22 2016 
Baron Growth Fund New Purchases Part 3 Feb 08 2016 
Popular Guru Stocks With High, Growing Yield Feb 03 2016 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
Brian Rogers Buys Occidental Petroleum, Tyco In Q2 Jul 16 2015 

More From Other Websites
Quest Diagnostics (DGX) Launches HBV Quantitative Test Jan 20 2017
Quest Diagnostics CEO reveals the best and worst things about Obamacare Jan 18 2017
Coverage initiated on Quest Diagnostics by Deutsche Bank Jan 18 2017
Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess... Jan 18 2017
Quest Diagnostics (DGX) Q4 Earnings: What Lies in Store? Jan 16 2017
Quest Diagnostics To Release Fourth Quarter And Full Year 2016 Financial Results On January 26 Jan 11 2017
Quest Diagnostics CEO Rusckowski ‘Hopeful’ on Obamacare Jan 10 2017
What should a potential Obamacare replacement look like? Jan 10 2017
Inovalon Extends Partnership With Anthem Jan 09 2017
Quest Diagnostics Achieves Perfect Score On 2017 Human Rights Campaign Corporate Equality Index Jan 06 2017
Quest Diagnostics Achieves Perfect Score On 2017 Human Rights Campaign Corporate Equality Index Jan 06 2017
Quest Diagnostics To Speak At The 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Quest Gets Price-Target Hike On Safeway Tie; Ancestry.com Opportunity Jan 03 2017
Quest Diagnostics: Strong Q3, Strategic Initiatives Add Value Dec 28 2016
5 Rocket Stocks for Year-End Gains -- Micron, Intuitive Surgical and More Dec 27 2016
Bragar Eagel & Squire, P.C. Is Investigating Quest Diagnostics, Inc. (DGX) on Behalf of Patients... Dec 16 2016
Here Is Why Quest Diagnostics Will Put the Data Breach Behind It Dec 16 2016
QUEST DIAGNOSTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 16 2016
Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board Dec 15 2016
GoBio Or Go Home: Top Medical Stock BioTelemetry Tests Buy Point Dec 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)